Track the 티움바이오 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 티움바이오 has published 24 insider filings. Market capitalisation: €120.3bn. The latest transaction was reported on 24 June 2026 (Other). Among the most active insiders: 김훈택. The full history is accessible without an account.
24
Insider Decl.
n/a
Thresholds
n/a
6 ops.
Buy Volume
n/a
5 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 25,326 of 29,063 companies
24.8
score / 100
Value
15
Quality
35
FCF yld-11%
Earn yld-12%
EV/EBITDA·
ROE-32%
Gross mgn41%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.